Form 4 for DXCM Dexcom
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-17 · accession 0001093557-25-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-19 | 2025-03-17 | DXCM | Heller Bridgette P | Dir | S - Sale | $70.33 | -352 | 23.0K | -2% | -$24.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | S | D | 352 | $70.33 | 22,997 | D | — | — | (F1) On February 25, 2024, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. (F2) Included in this number are 2,618 unvested restricted stock units which were granted on May 22, 2024 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2025 Annual Meeting of Stockholders. |